NCT07241819 2025-11-21
Ivonescimab Monotherapy or in Combination With Chemotherapy as Neoadjuvant/Adjuvant Therapy for Resectable Non-small Cell Lung Cancer
Peking University Cancer Hospital & Institute
Phase 2 Not yet recruiting
Clinical Trials
1 trialsNot yet recruiting × II-IIIB (T3N2) Resectable Non-small Cell Lung Cancer × Surgical Procedures, Operative × Clear all